On September 19, 2025, Advanced Biomed Inc. announced the launch of its new product, A+PerfusC™, an Integrated Perfusion 3D Cell Culture Platform aimed at enhancing precision medicine and drug discovery. This development signifies a strategic move towards innovative biomedicine solutions.